![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ] Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13385/1/fig-1-full.png)
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
![Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10354-022-00912-7/MediaObjects/10354_2022_912_Fig1_HTML.png)
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
![Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis | HTML Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis | HTML](https://www.mdpi.com/hemato/hemato-02-00042/article_deploy/html/images/hemato-02-00042-g001.png)
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis | HTML
![High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/7/5/e831/F1.large.jpg)
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation
![Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E](https://pubs.rsc.org/image/article/2018/CC/c8cc04396e/c8cc04396e-f2_hi-res.gif)
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2009.151/MediaObjects/41581_2009_Article_BFnrneph2009151_Fig1_HTML.jpg)
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g002.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
![Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014 Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014](https://journals.sagepub.com/cms/10.1177/0004563213518758/asset/images/large/10.1177_0004563213518758-fig1.jpeg)
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
![Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection](https://static-02.hindawi.com/articles/bmri/volume-2019/8382132/figures/8382132.fig.001.jpg)
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S151684841500170X:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR1aFJOKb7qLd+WBf18Ptk/O8dVG5SMqADZji5skBxdmL4Eg+W9M/1HLX6WWOJItH9fTBgdwdPEZR3glHibTrvPAkYyjMi4Vjd55uqJ5DGqlkRjnxsYiTDCVHBAPb+c3uF5KJgKx9Yu19zRC8/kXWnMHN6Ds6zmD73kq5Ioodt3NBUa3ChmlLkrLmWBRMQjlKUpU5vh8NPt70tzEUPueps4+UMKJIGHvgVC7vk0IbGgjd78Ub7YIgCdbhdCEpxhTRgh0xNGSd+WSX2g7oP8mFZzQ)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis | PLOS ONE
![Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent | Semantic Scholar Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d3cb9e38dcaefe04aed7470fc22afca22d505890/5-Figure4-1.png)